Loading clinical trials...
Loading clinical trials...
This is a retrospective and prospective multicenter observational study with the aim to evaluate the real-life use of Fostamatinib in adult patients with chronic ITP, refractory to other treatments.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT07093606 · ITP - Immune Thrombocytopenia
NCT06352281 · ITP - Immune Thrombocytopenia
NCT07014904 · ITP - Immune Thrombocytopenia
NCT06093529 · ITP - Immune Thrombocytopenia
AON SS. ANTONIO E BIAGIO E C. ARRIGO - SS emostasi e trombosi
Alessandria
SOD Clinica Ematologica AOU Ospedali Riuniti Umberto I GM Lancisi G Salesi
Ancona
UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
Bari
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions